Circulating tissue kallikrein levels correlate with severity of carotid atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 6, 2004, Pages 1104-1110

  Porcu, Paolo ^a   Emanueli, Costanza ^b   Desortes, Elisa ^b   Marongiu, Giovanni M ^a   Piredda, Franco ^a   Chao, Lee ^c   Chao, Julie ^c   Madeddu, Paolo ^a,b,d  

^a UNIVERSITY OF SASSARI   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d University of Medicine   (Italy)

Author keywords

Angiogenesis; Atherosclerosis; Brain; Growth factors; Inflammation; Revascularization

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; C REACTIVE PROTEIN; TISSUE KALLIKREIN; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; KALLIKREIN KININ SYSTEM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID STENOSIS; CASE-CONTROL STUDIES; ENDARTERECTOMY, CAROTID; FEMALE; FIBROBLAST GROWTH FACTOR 2; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; TISSUE KALLIKREINS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 2942550569     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000128126.57688.a9     Document Type: Article

References (33)

1. North Am Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445-453.
2. European Carotid Surgery Trialists' Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379-1387.
3. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr., Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, Am Heart Association. Circulation. 1995;92:1355-1374.
4. Barnett HJM, Eliasziw M, Meldrum HE. The identification by imaging methods of patients who might benefit from carotid endoarteriectomy. Arch Meurol. 1995;52:827-831.
5. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363-369.
6. Folsom AR, Pankow JS, Tracy RP, Arnett DK, Peacock JM, Hong Y, Djousse L, Eckfeldt JH; Investigators of the NHBLI Family Heart Study. Association of C-reactive protein with markers of prevalent atherosclerosis disease. Am J Cardiol. 2001;88:112-117.
7. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, Lo KM, Gillies S, Javaherian K, Folkman J. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA. 2003;100: 4736-4741.
8. Celletti FL, Waugh JM, Amabile PG, Brendolan PG, Hilfiker PR, Dake MD. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med. 2001;7:425-429.
9. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke. 1994;25: 1794-1798.
10. Kawamata T, Speliotas EK, Finklestein SP. The role of polypeptide growth factors in recovery from stroke. Adv Neurol. 1997;73:377-382.
11. Wei L, Erinjeri JP, Rovainen CM, Woolsey TA. Collateral growth and angiogenesis around cortical stroke. Stroke. 2001;32:2179-2184.
12. Van Belle E, Rivard A, Chen D, Silver M, Bunting S, Ferrara N, Symes JF, Bauters C, Isner JM. Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation. 1997;96:2667-2674.
13. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Bruggen N, Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier function in the ischemic brain. J Clin Invest. 2000;106:829-838.
14. Zhang JJ, Chao L, Chao L. Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl alt-sensitive rats. Stroke. 1999;30:1925-1932.
15. Slevin M, Krupinski J, Slowik A, Kumar P, Szczudlik A, Gaffney J. Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke. 2000;31:1863-1870.
16. Heeschen C, Dimmeler S, Hamm CW, Boersma E, Zeiher AM, Simoons ML; CAPTURE (c7E3 Anti-Platelet Therapy in Unstable REfractory angina) Investigators. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes. Circulation. 2003;107:524-530.
17. Porcu P, Emanueli C, Kapatsoris M, Chao J, Chao L, Madeddu P. Reversal of angiogenic growth factor upregulation by revascularization of lower limb ischemia. Circulation. 2002;105:67-72.
18. Tegos TJ, Stavropoulos P, Sabetai MM, Khodabakhsh P, Sassano A, Nicolaides AN. Determinants of carotid plaque instability: echoicity versus heterogeneity. Eur J Vasc Endovasc Surg. 2001;22:22-30.
19. Willeit J, Kiechl S, Oberhollenzer F, Rungger G, Egger G, Bonora E, Mitterer M, Muggeo M. Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. Arterioscler Thromb Vasc Biol. 2000;20:529-537.
20. Wang TJ, Nam BH, Wilson PW, Wolf PA, Levy D, Polak JF, D'Agostino RB, O'Donnell CJ. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2002;22:1662-1667.
21. Tracy RP, Psaty BM, Macy E, Bovill EG, Cushman M, Cornell ES, Kuller LH. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 1997; 7:2167-2176.
22. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr., Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention; Am Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the Am Heart Association. Circulation. 2003;107:499-511.
23. Chen HH, Chien CH, Liu HM. Correlation between angiogenesis and basic fibroblast growth factor expression in experimental brain infarct. Stroke. 1994;25:1651-1657.
24. Ferns GAA, Stewart-Lee AL, Anggard EE. Arterial response to mechanical injury: balloon catheter de-endothelialization. Atherosclerosis. 1992;92:89-104.
25. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A. 1991;88:3739-3743.
26. Emanueli C, Minasi A, Zacheo A, Chao J, Chao L, Salis MB, Straino S, Tozzi MG, Smith R, Gaspa L, Bianchini G, Stillo F, Capogrossi MC, Madeddu P. Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia. Circulation. 2001;103:125-132.
27. Emanueli C, Salis MB, Pinna A, Stacca T, Milia AF, Spano A, Chao J, Chao L, Sciola L, Madeddu P. Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene transfer. Circulation. 2002;106: 993-999.
28. Carmeliet P. Clotting factors build blood vessels. Science. 2001;293: 1602-1605.
29. Zhang Z, Chopp M. Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. Trends Cardiovasc Med. 2002;12:62-66.
30. Kendall RL, Wang G, Thomas KA. Identification of a natural soluble form of the vascular endothelial growth factor, FLT-1, and its heterodimerization with KDR. Biohem Biophys Res Commun. 1996;226: 324-328.
31. Madeddu P, Gherli T, Bacciu PP, Maioli M, Glorioso N. A kallikrein-like enzyme in human vascular tissue. Am J Hypertens. 1993;6:344-348.
32. Madeddu P, Varoni MV, Demontis MP, Fattaccio MC, Parpaglia PP, Glorioso N. A kallikrein-like enzyme in the aorta of normotensive and hypertensive rats. Hypertension. 1994;23:899-902.
33. Manolio T. Novel risk markers and clinical practice. N Engl J Med. 2003;349:1587-1589.